European Commission logo
español español
CORDIS - Resultados de investigaciones de la UE
CORDIS

Quantitative detection of bacterial endotoxin by novel nanotechnological approaches

Descripción del proyecto

Detección innovadora de endotoxinas mediante nanotecnología

Las normativas de seguridad exigen la detección cuantitativa e imparcial de endotoxinas bacterianas en los productos destinados a uso médico y al desarrollo de fármacos. Los análisis actuales del lisado de amebocitos de Limulus tienen una fiabilidad limitada y no pueden aplicarse a todos los productos y sustancias. En el proyecto ENDONANO, financiado por las Acciones Marie Skłodowska-Curie, se aprovechará un concepto novedoso basado en la capacidad de las nanopartículas metálicas para adsorber endotoxinas, así como métodos de detección basados en balizas moleculares. El objetivo es desarrollar un análisis de cuantificación de endotoxinas que funcione en matrices complejas y en una amplia gama de condiciones. ENDONANO formará a cuatro investigadores de doctorado a través de cursos sobre capacidades científicas, técnicas y transferibles, participación en eventos científicos y redes de contactos.

Objetivo

ENDONANO (Quantitative detection of bacterial endotoxin by novel nanotechnological approaches) addresses a key regulatory and safety issue, i.e. the unbiased quantitative detection of bacterial endotoxin in products for medical use and in drug development and toxicological studies. The currently adopted LAL assays are reliable only in limited conditions and prone to interference at several levels, and therefore cannot be applied to all products and substances. ENDONANO will exploit new concepts, based on the capacity of metal nanoparticles to adsorb endotoxin, and new detection methods, based on molecular beacons, for developing novel assays to quantitatively detect endotoxin in complex matrices and in a wide range of conditions. The scientific and technological goals of ENDONANO include: 1. Investigating the capacity of endotoxin to specifically inducing inflammatory reactions in human primary blood cells; 2. Developing new methods based on endotoxin capture by metal nanoparticles in complex matrices (biological fluids, emulsions, gels, etc.); 3. Designing and implementing signal generation and detection methods for the quantitative endotoxin measurement; 4. Planning assay prototypes to be developed and validated for commercial purposes. ENDONANO will train 4 PhD students in an overarching training programme that will include training-by-research, courses of technical, scientific, and transferrable skills, active participation to public scientific events, and intense intersectoral networking. The ENDONANO consortium encompasses three academic institutions with strong expertise in inflammation, advanced biosensing, and top expertise in nanotechnology and use of nanoparticles for modulating bacterial functions, two SMEs expert in development and commercialisation of diagnostic detection assays and one biotech company specialised in (magnetic) microbead technology, and two Participant Organisations (SMEs). All have proven experience in higher education and training,

Coordinador

CONSIGLIO NAZIONALE DELLE RICERCHE
Aportación neta de la UEn
€ 261 499,68
Dirección
PIAZZALE ALDO MORO 7
00185 Roma
Italia

Ver en el mapa

Región
Centro (IT) Lazio Roma
Tipo de actividad
Research Organisations
Enlaces
Coste total
€ 261 499,68

Participantes (6)

Socios (2)